This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bertuzzi, A. Articles by Salinari, S. Search for Related Content PubMed PubMed Citation Articles by Bertuzzi, A. Articles by Salinari, S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB DODECANEDIOIC ACID Social Bookmarking                         What's this?

Pharmacokinetic Analysis of Dodecanedioic Acid in Humans From Bolus Data

Istituto di Analisi dei Sistemi ed Informatica del CNR, Roma, Italy

Geltrude Mingrone

Istituto di Clinica Medica, Università Cattolica del Sacro Cuore, Roma, Italy

Alberto Gandolfi

Istituto di Analisi dei Sistemi ed Informatica del CNR, Roma, Italy

Aldo Virgilio Greco

Istituto di Clinica Medica, Università Cattolica del Sacro Cuore, Roma, Italy

Serenella Salinari

Dipartimento di Informatica e Sistemistica, Università di Roma "La Sapienza," Roma, Italy

Background: Excretion and tissue uptake of dodecanedioic acid (C12), a proposed alternative fuel substrate, was investigated in humans by bolus experiments. Methods: Seven overnight-fasting healthy male volunteers received IV a bolus (1 g) of C12. Blood samples were collected after C12 administration at intervals of 15 minutes, and C12 serum concentration was measured by high-performance liquid chromatography. C12 excretion in 24-hour urine was measured. Binding of C12 in human serum was determined in separate equilibrium dialysis experiments by means of an isotopic compound (disodic salt of (1,12)¹⁴C-dodecanedioic acid). A two-compartment model was used for describing C12 kinetics. Results: The excreted amount of C12 in 24-hour urine was found to be, on the average, 1.62% of administered dose. The apparent number of binding sites per albumin molecule was 3.1 ± 0.2 (estimate ± SE) with an affinity constant of 6.4 ± 1.8 mM^-1. The distribution volume of central compartment was 5.56 ± 3.13 L and that of peripheral compartment was 87.4 ± 30.4 L. The rate constant of exchange between compartments was 4.60 ± 3.50 L/min, that of urinary excretion 25.6 ± 15.5 mL/min, and that of tissue uptake 2.17 ± 0.86 L/min. Conclusions: These results are promising for C12 utilization in parenteral nutrition, because C12 elimination in urine is low whereas tissue uptake appears to be rather efficient. (Journal of Parenteral and Enteral Nutrition 19:498-501, 1995)

Journal of Parenteral and Enteral Nutrition, Vol. 19, No. 6, 498-501 (1995)
DOI: 10.1177/0148607195019006498


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. Panunzi, A. De Gaetano, and G. Mingrone Approximate linear confidence and curvature of a kinetic model of dodecanedioic acid in humans Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E915 - E922. [Abstract] [Full Text] [PDF]

				A. Bertuzzi, G. Mingrone, A. Gandolfi, A. V. Greco, and S. Salinari Disposition of Dodecanedioic Acid in Humans J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 846 - 852. [Abstract] [Full Text]

				G. Mingrone, A. De Gaetano, A. V. Greco, E. Capristo, G. Benedetti, M. Castagneto, and G. Gasbarrini Comparison Between Dodecanedioic Acid and Long-Chain Triglycerides as an Energy Source in Liquid Formula Diets JPEN J Parenter Enteral Nutr, March 1, 1999; 23(2): 80 - 84. [Abstract] [PDF]

				A. de Gaetano, G. Mingrone, M. Castagneto, G. Benedetti, A. V. Greco, and G. Gasbarrini Kinetics of dodecanedioic acid triglyceride in rats Am J Physiol Endocrinol Metab, March 1, 1999; 276(3): E497 - E502. [Abstract] [Full Text] [PDF]